Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 35 filings·Updated 26 Sept 2026
Showing 10 of 35 filings.
26 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Vikas Lifecare Limited: Trading Window closed from October 01, 2026 until expiry of 48 (Forty-Eight) hours after the declaration of the Unaudited Financial Results for the quarter and half year ended September 30, 2026

Vikas Lifecare Limited: Trading Window closed from October 01, 2026 until expiry of 48 (Forty-Eight) hours after the declaration of the Unaudited Financial Results for the quarter and half year ended September 30, 2026

Filed 12:53View Source
17 Sept 20261 filing
Company UpdateGeneral

ROC grants 2 months 28 days AGM extension for Vikas Lifecare 2026

AGM extension approval

  • ROC Delhi-II approved extension of time for holding AGM for FY2026 by 2 months 28 days.
  • The extension was granted under Section 96 of the Companies Act, 2013.
  • AGM to be convened within the extended period; date to be announced.
  • Application SRN AC5745771 filed on 01/09/2026 seeking extension.
  • ROC letter dated 16/09/2026 granting extension.
  • Accounting year ended 31/03/2026; AGM due 30/09/2026 under Section 96.
Filed 15:27View Source
8 Sept 20261 filing
Company UpdateGeneral

Vikas Lifecare Applies for ROC extension of AGM timing for FY2026

AGM extension filing

  • Company filed with ROC Delhi under Section 96 seeking extension of time to convene AGM for FY2026.
  • Approval pending; AGM will be held within the extended period once ROC approves.
  • Company will inform stock exchanges upon ROC approval.
Filed 19:21View Source
10 Aug 20261 filing
Company UpdateReply to Clarification- Financial results

Vikas Lifecare Reports Audited Standalone & Consolidated FY2026 Results; Board Meeting Outcome

Board Update

  • Board approves standalone and consolidated Audited financial results for year ended 31 March 2026.
  • Auditor's report on standalone results includes a qualified opinion.

Key Matters

  • Settlement with HSPL for ₹52 crore; agreement dated 30 May 2026.
  • Ebix investment under Eraaya Lifespaces; 51% EIHL shares transferred; approvals pending.
  • Loans and investments not compliant with Section 186; repayment defaults noted.
  • Related party transactions with promoter group; shareholder approvals pending.
  • Disposal of 51.38% stake in Shashi Beriwal & Co; loss ₹7.06 crore.
  • Sale of Arihant Nagar Delhi property; loss ₹2.56 crore.
  • Impairment on advance for Abhhyam acquisition; recovery disputed.
  • ED provisional attachment of assets; ₹1,333.84 lakhs; challenge ongoing.
  • SEBI investigation ongoing; no final order yet.
  • FEMA/ODI compliances pending; regularisation underway.

Financial Highlights

  • Standalone revenue from operations for year ended 31 Mar 2026: ₹49,205.46 lakh.
  • Standalone total income for year ended 31 Mar 2026: ₹62,555.60 lakh.
  • Standalone net profit after tax for year ended 31 Mar 2026: ₹8,617.23 lakh.
  • Consolidated revenue for year ended 31 Mar 2026: ₹63,510.33 lakh.
  • Consolidated net profit for year ended 31 Mar 2026: ₹1,836.19 lakh.
  • Consolidated total comprehensive income for year ended 31 Mar 2026: ₹1,953.52 lakh.
Filed 10:56View Source
31 Jul 20261 filing
Company UpdateClarification - Financial Results

The Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 15:12View Source
17 Jul 20261 filing
Company UpdateClarification - Financial Results

The Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 12:15View Source
15 Jul 20261 filing
Company UpdateGeneral

Promoter Vikas Garg taken into custody by Directorate of Enforcement; company says operations unaffected

Promoter arrest update

  • Promoter Mr. Vikas Garg has been taken into custody by the Directorate of Enforcement.
  • The company states there is no material impact on operations, with business continuing in ordinary course.
  • The company is evaluating the development with legal advisors and will take appropriate steps.
  • Estimated amount involved is not ascertainable.
  • Disclosures under Regulation 30 with Annexure 1 have been provided.
  • Occurrence date July 14, 2026; filing dated July 15, 2026.
  • No governance changes disclosed in this update.
Filed 21:27View Source
11 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate confirms furnishing of dematerialized/rematerialized details to all stock exchanges

Exchange reporting status

  • Details of dematerialized and rematerialized securities were furnished to all stock exchanges where shares are listed.
Filed 16:57View Source
9 Jul 20261 filing
Company UpdateGeneral

Vikas Lifecare reports audited FY2026 results, notes HSPL settlement and Ebix investment developments

Board action & audit status

  • Board approved standalone and consolidated audited results for quarter and year ended 31 March 2026.
  • Auditor’s report on standalone results carries a qualified opinion.

Standalone FY2026 financials

  • Standalone FY2026 net profit after tax: ₹8,617.23 lakh.
  • Standalone FY2026 total comprehensive income: ₹8,581.64 lakh.

HSPL settlement

  • Settlement with HSPL for ₹52 crore principal; ₹3 crore additional compensation payable.
  • ₹3 crore compensation not recognized in FY2026 results; balance outstanding remains unconfirmed.

Ebix investment

  • 51% EIHL transferred to VLL; investment accounted as associate; approvals pending.

Related party transactions

  • Related party transactions with promoter group/subsidiaries; shareholder approvals pending.

Regulatory filings & ODI compliance

  • ODI forms and RBI filings pending; regularisation in progress across jurisdictions.

Disposals, impairments, and regulatory actions

  • Tax demands ₹26.44 crore; ED attachment on properties; SEBI investigation ongoing; no material impact expected.
Filed 16:54View Source
27 Jun 20261 filing
Company UpdateNewspaper Publication

Newspaper Advertisement for Financial Results quarter and year ended March 31, 2026

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 13:17View Source
Showing 10 of 35 filings